Avid Radiopharmaceuticals is a company developing molecular imaging agents for chronic human diseases. It aims to combine medical imaging and CNS development experience for pre-symptomatic disease detection. The company focuses on such conditions as Alzheimer's disease, dementia with Lewy Bodies, Parkinson's disease, and diabetes mellitus.